Tag: life sciences
-

FDA Analyzing Real-World Evidence on Covid-19
The Food and Drug Administration is analyzing collections of health records to gain more evidence-based insights into the course of the Covid-19 pandemic.
-

Antibody Neutralizes Covid-19, SARS Viruses
An academic-industry team discovered that an antibody produced during the 2003 SARS outbreak can neutralize similar viruses causing Covid-19 infections.
-

Trial Tests Liquid Biopsy Feasibility in Lung Cancer
Companies that offer biotechnology, diagnostics, and analytics are testing liquid biopsies to make personalized diagnosis and care feasible for lung cancer patients.
-

Covid-19 Vaccine Generates Immune Response
First results from a clinical trial testing a vaccine to protect against Covid-19 infections show the vaccine produces an immune response in healthy participants.
-

Infographic – Vaccines Stop Infectious Diseases
One of the reasons so much depends on a vaccine is due to their track record in preventing the spread of infectious diseases, and almost completely eradicating the disease in many cases.
-

FDA Stops Home Covid-19 Diagnostic Test
The Food and Drug Administration asked designers of a Covid-19 test collecting samples at home for research to stop giving results to individuals.
-

Covid-19 Lung Disease Trial Adds Treatments
A clinical trial testing treatments for lung damage in severe Covid-19 cases is adding the anti-viral drug remdesivir and convalescent plasma to its protocol.
-

FDA Issues Covid-19 Therapy Trials, Review Guidance
The Food and Drug Administration issued new regulatory guidance on clinical trials and streamlined review processes for Covid-19 treatments.
-

Mayo Clinic, A.I. Company Study Covid-19 Heart Disease
A developer of software to diagnose heart disease from images with artificial intelligence is assessing Covid-19 infection patients for heart ailments with the Mayo Clinic.
-

Int’l Group Backs Novavax Covid-19 Vaccine
A global consortium is funding a biotechnology company’s clinical trials and manufacturing plans for a vaccine protecting against Covid-19 viruses.